Is there a role for targeted medical therapies in patients with craniopharyngiomas?

    loading  Checking for direct PDF access through Ovid


“Our understanding of the molecular mechanisms underlying papillary craniopharyngiomas has been advanced as a result of recent observations implicating somatic BRAF gene mutations in the pathogenesis of these uncommon, yet potentially devastating, tumors.”

Related Topics

    loading  Loading Related Articles